1
TITLE: Lenvatinib plus Pembrolizumab for Advanced Endometrial Cancer
AUTHORS: Makker V.; Colombo N.; Casado C Herráez; Santin A.D.; Colomba E.; David Scott Miller ; Fujiwara K.; Pignata S.; Baron-Hay S.; Ray-Coquard I.; Shapira-Frommer R.; Ushijima K.; Sakata J.; Yonemori K.; Kim Y.M.; Guerra E.M.; Sanli U.A.; McCormack M.M.; Smith A.D.; Keefe S.; Bird S.; Dutta L.; Orlowski R.J.; Lorusso D.; ...More
PUBLISHED: 2022, SOURCE: New England Journal of Medicine, VOLUME: 386, ISSUE: 5
INDEXED IN: Scopus CrossRef: 359